| 摘要 |
FIELD: medicine, pharmaceutics. ^ SUBSTANCE: group of inventions refers to a drug for gastroduodenal diseases caused by Helicobacter pylori, and to a method of treating these diseases by inhibiting apoptosis in gastric epitheliocytes, administering the drug containing an amount of a peptide of formula H-Glu-Asp-Gly-OH effective with respect to Helicobacter pylori. The invention also concerns a pharmaceutical composition and applying it. ^ EFFECT: group of inventions provides producing a new group of the preparations containing biologically active compounds on the basis of peptides, exhibiting specific activity with respect to Helicobacter pylori. ^ 9 cl, 4 ex, 1 tbl, 17 dwg |
